• Papathemelis T, Ortmann O, Kohl C, Neuser P, Tol KK, Klinkhammer-Schalke M, Ugocsai P, Walter CB, Rottmann M, Real C, Justenhoven C, Robers G, Schneider C, Gerken M, Sackmann A, Kim-Wanner SZ. Treatment of endometrial cancer from 2000 to 2020 in Germany: a retrospective population based cohort study. J Cancer Res Clin Oncol. 2024 May 27;150(5):279. doi: 10.1007/s00432-024-05772-9. PMID: 38802682; PMCID: PMC11129991.


  • Buschmann L, Wellmann I, Bonberg N, Wellmann J, Hense HW, Karch A, Minnerup H. Isolating the effect of confounding from the observed survival benefit of screening participants - a methodological approach illustrated by data from theGerman mammography screening programme. BMC Med. 2024 Jan 30;22(1):43. doi: 10.1186/s12916-024-03258-6.



  • Dieckmann KP, Isbarn H, Trocchi P, Kießling M, Wülfing C, Stang A. No evidence for seasonal variations oft he incidence of testicular germ cell tumours in Germany. PLOS One. 2023 May 26; 18(5). e0286309. doi.org/10.1371/journal.pone.0286309.


  • Eisfeld C, Kajüter H, Möller L, Wellmann I, Shumilov E, Stang A. Time trends in survival and causes of death in multiple myeloma: a population-based study from Germany. BMC Cancer. 2023 Apr 6;23(1):317. doi: 10.1186/s12885-023-10787-5.


  • Jansen L, Schwettmann L, Behr C, Eberle A, Holleczek  B, Justenhoven C, Kajüter H, Manz K, Peters F, Pritzkuleit R, Schmidt-Pokrzywniak A, Sirri E, Tetzlaff F, Voigtländer S, Arndt V. Trends in cancer incidence by socioeconomic deprivation in Germany in 2007 to 2018: An ecological registry-based study. Int J Cancer 2023; 2023 Aug 4. doi: 10.1002/ijc.34662


  • Jansen L, Moratin J, Behr C, Holleczek B, Luttmann S, Peters F, Robers G, Schmidt-Pokrzywniak A, Pritzkuleit R, Sirri E, Stang A, Arndt V. Epidemiologie von Kopf-Hals-Tumoren in Deutschland. Onkologie. 2023 Jan; 29 5-11. doi.org/10.1007/s00761-022-01265-x   


  • Möller L, Wellmann I, Stang A, Kajüter H. The Epidemiology of Colorectal Cancer in Younger and Older Patients. Dtsch Arztebl Int. 2023 Apr 21; arztebl.m2023.0041. doi: 10.3238/arztebl.m2023.0041.


  • Möller L, Stang A, Kajüter H. Epidemiologie des Nierenzellkarzinoms in Deutschland 2019. Onkologie. 2023 Jun; 29 565–570. doi.org/10.1007/s00761-023-01362-5


  • Stang A, Wellmann I, Holleczek B, Fell B, Kajüter H. Malignome der extra- und intrahepatischen Gallenwege und des Pankreas in Deutschland 2009–2019: Inzidenz und Überleben. Onkologie. 2023. https://doi.org/10.1007/s00761-023-01395-w



  • Clausen S, Falk M, Oesterling F, Fehr A, Stang A, Boecker W, Gesk S, Schatz S, Stenman G, Tiemann K, Loening T, Friedrich RE. Outcome of Ordinary Polymorphous Adenocarcinomas of the Salivary Glands in Comparison With Papillary and Cribriform Subtypes. Anticancer Res. 2022 Mar;42(3):1455-1463. doi: 10.21873/anticanres.15616.


  • Nachtsheim L, Mayer M, Meyer MF, Oesterling F, Kajueter H, Arolt C, Quaas A, Klussmann JP, Wolber P. Incidence and clinical outcome of primary carcinomas of the major salivary glands: 10-year data from a population-based state cancer registry in Germany. J Cancer Res Clin Oncol. 2022 Aug 22. doi: 10.1007/s00432-022-04278-6.


  • Oesterling F, Kajüter H, Nachtsheim L, Löning T, Stang A. Letter: Parotid gland metastases of cutaneous squamous cell carcinoma - a corroboration at population level. Head Neck Pathol. 2022 Apr 15. doi: 10.1007/s12105-022-01443-8. Online ahead of print.


  • Stang A, Trocchi P, Kajüter H, Trabert B, Oosterhuis JW, McGlynn KA. Age-incidence patterns of seminoma and nonseminoma among males and females in Germany and the United States, 2008-2016. Andrology 2022. doi 10.1111/andr. 13282


  • Stang A, Wellmann I, Holleczek B, Fell B, Terner S, Lutz MP, Kajüter H. Incidence and relative survival of pancreatic adenocarcinoma and pancreatic neuroendocrine neoplasms in Germany, 2009-2018. An in-depth analysis of two population-based cancer registries. Cancer Epidemiol. 2022 Aug;79:102204. doi: 10.1016/j.canep.2022.102204.




  • Fehr A, Werenicz S, Trocchi P, Falk M, Friedrich RE, Stammler A, Stang A, Oesterling F, Khil L, Stenman G, Böcker W, Tiemann K, Löning T. Mucoepidermoid carcinoma of the salivary glands revisited with special reference to histologic grading and CRTC1/3-MAML2 genotyping. Virchows Arch. 2021 Nov;479(5):975-985. doi: 10.1007/s00428-021-03146-x.


  • Finke I, Behrens G, Maier W, Schwettmann L, Pritzkuleit R, Holleczek B, Kajüter H, Gerken M, Mattutat J, Emrich K, Jansen L, Brenner H; German Cancer Survival Working Group. Small-area analysis on socioeconomic inequalities in cancer survival for 25 cancer sites in Germany. Int J Cancer. 2021 Aug 1;149(3):561-572. doi: 10.1002/ijc.33553.


  • Jansen L, Kanbach J, Finke I, Arndt V, Emrich K, Holleczek B, Kajüter H, Kieschke J, Maier W, Pritzkuleit R, Sirri E, Schwettmann L, Erb C, Brenner H, Group FTGCSW. Estimation of the Potentially Avoidable Excess Deaths Associated with Socioeconomic Inequalities in Cancer Survival in Germany. Cancers (Basel). 2021 Jan 19;13(2):357. doi: 10.3390/cancers13020357.


  • Kajüter H, Wellmann I, Khil L, Jöckel KH, Zhang C, Fink AM, Hallek M, Stang A. Survival of patients with chronic lymphocytic leukemia before and after the introduction of chemoimmunotherapy in Germany. Blood Cancer J. 2021 Oct 29;11(10):174. doi: 10.1038/s41408-021-00556-7.


  • Kowall B, Standl F, Oesterling F, Brune B, Brinkmann M, Dudda M, Pflaumer P, Jöckel KH, Stang A. Excess mortality due to Covid-19? A comparison of total mortality in 2020 with total mortality in 2016 to 2019 in Germany, Sweden and Spain. PLoS One. 2021 Aug 3;16(8):e0255540. doi: 10.1371/journal.pone.0255540. eCollection 2021.


  • Mahanani MR, Kaucher S, Kajüter H, Holleczek B, Becher H, Winkler V. Colorectal Cancer among Resettlers from the Former Soviet Union and in the General German Population: Clinical and Pathological Characteristics and Trends. Int J Environ Res Public Health. 2021 Apr 25;18(9):4547. doi: 10.3390/ijerph18094547.


  • Standl F, Kowall B, Frost AK, Brune B, Brinkmann M, Dudda M, Oesterling F, Jansen P, Jöckel KH, Stang A. Calculating the number of undetected active SARS-CoV-2 infections from results of population-wide antigen tests. J Med Life. 2021 Nov-Dec;14(6):797-801. doi: 10.25122/jml-2021-0243.


  • Stang A, McMaster ML, Sesterhenn IA, Rapley E, Huddart R, Heimdal K, McGlynn KA, Oosterhuis JW, Greene MH. Histological Features of Sporadic and Familial Testicular Germ Cell Tumors Compared and Analysis of Age-Related Changes of Histology. Cancers (Basel). 2021 Apr 1;13(7):1652. doi: 10.3390/cancers13071652.




  • Arndt V, Holleczek B, Kajüter H, Luttmann S, Nennecke A, Zeissig SR, Kraywinkel K, Katalinic A. Data from Population-based Cancer Registration for Secondary Data Analysis: Methodological Challenges and Perspectives. Gesundheitswesen. 2020 Mar;82(S 01):S62-S71. doi: 10.1055/a-1009-6466.


  • Jansen L, Holleczek B, Kraywinkel K, Weberpals J, Schröder CC, Eberle A, Emrich K, Kajüter H, Katalinic A, Kieschke J, Nennecke A, Sirri E, Heil J, Schneeweiss A, Brenner H. Divergent Patterns and Trends in Breast Cancer Incidence, Mortality and Survival Among Older Women in Germany and the United States. Cancers (Basel). 2020 Aug 26;12(9):2419. DOI: 10.3390/cancers1209241


  • Kaucher S, Khil L, Kajüter H, Becher H, Reder M, Kolip P, Spallek J, Winkler V, Berens EM. Breast cancer incidence and mammography screening among resettlers in Germany. BMC Public Health. 2020 Mar 30;20(1):417. DOI: 10.1186/s12889-020-08534-7


  • Khil L, Heidrich J, Wellmann I, Kääb-Sanyal V, Weigel S, Heindel W, Hense HW, Heidinger O. Incidence of advanced-stage breast cancer in regular participants of a mammography screening program: a prospective register-based study. BMC Cancer. 2020 Mar 4;20(1):174. doi: 10.1186/s12885-020-6646-5.


  • Lindblad A, Kaucher S, Jaehn P, Kajüter H, Holleczek B, Lissner L, Becher H, Winkler V. The Incidence of Intestinal Gastric Cancer among Resettlers in Germany-Do Resettlers Remain at an Elevated Risk in Comparison to the General Population? Int J Environ Res Public Health. 2020 Dec 9;17(24):9215. DOI: 10.3390/ijerph17249215


  • Stang A, Kühling L, Khil L, Kajüter H, Schützendübel A, Mattauch V. Drop in cancer reporting by pathologists in North Rhine-Westphalia, Germany, during the COVID-19 lockdown. Dtsch Arztebl Int 2020;117:886-887; DOI: 10.3238/arztebl.2020.0886


  • Stang A, Wellmann I, Kajüter H, Trocchi P, Becker JC, Green AC, Jöckel KH, Khil L. Differences in site-specific incidence and relative survival of cutaneous and mucocutaneous genital squamous cell carcinoma in Germany, 2007-2015. Int J Cancer. 2020 Nov 15;147(10):2772-2779. doi: 10.1002/ijc.33109.




  • Arndt V, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Doege D, Thong MSY, Brenner H.: Return to work after cancer. A multi-regional population-based study from Germany. Acta Oncol. 2019 Feb 19:1-8. DOI: 10.1080/0284186X.2018.1557341.


  • Braun B, Kurosinski M, Khil L, Tio J, Krause-Bergmann B, Hense HW. The Mode of Detection is not associated with quality of life in women with breast cancer. Breast Care. 2019. DOI: 10.1159/000504662


  • Brunssen A, Jansen L, Eisemann N, Waldmann A, Weberpals J, Kraywinkel K, Eberle A, Holleczek B, Zeissig SR, Brenner H, Katalinic A; GEKID Cancer Survival Working Group. A population-based registry study on relative survival from melanoma in Germany stratified by tumor thickness for each histologic subtype. J Am Acad Dermatol. 2019 Apr;80(4):938-946. DOI: 10.1016/j.jaad. 2018.09.018


  • Doege D, Thong M, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Brenner H, Arndt V.: The role of psychosocial resources for long-term breast, colorectal, and prostate cancer survivors: prevalence and associations with health-related quality of life. Support Care Cancer. 2019 Jan;27(1):275-286. DOI: 10.1007/s00520-018-4317-8.


  • Doege D, Thong MSY, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B,  Pritzkuleit R, Waldeyer-Sauerland M, Waldmann A, Zeissig S, Jansen L, Brenner H, Arndt V.: Health-related quality of life in long-term disease-free breast cancer survivors versus female population controls in Germany.  Breast Cancer Res Treat. 2019. DOI:10.1007/s10549-019-05188-x


  • Jaehn P, Kaucher S, Pikalova LV, Mazeina S, Kajüter H, Becher H, Valkov M, Winkler V. A cross-national perspective of migration and cancer: incidence of five major cancer types among resettlers from the former Soviet Union in Germany and ethnic Germans in Russia. BMC Cancer BMC Cancer. 2019 Sep 2;19(1):869. doi: 10.1186/s12885-019-6058-6.


  • Prange A., Bokhof B., Polzer P., Tio J., Radke I., Heidinger, O., Heindel W., Weigel S.: Higher Detection Rates of Biologically Aggressive Breast Cancers in Mammography Screening than in the Biennial Interval. Fortschr Röntgenstr 2019; 191(02): 130-136. DOI: 10.1055/a-0657-3970.


  • Semjonow A, Hense HW, Schlößler K, Simbrich A, Borowski M, Bothe C, Kruse K, Tiedje D, Kuss K, Adarkwah CC, Maisel P, Jendyk R, Kurosinski MA, Gerß J, Heidinger O, Tschuschke C, Becker R, Roobol MJ, Bangma C, Donner-Banzhoff N.: Development and Prospective Randomized Evaluation of a Decision Aid for Prostate-specific Antigen-based Early Detection of Prostate Cancer in Men Aged Between 55 and 69Yr: The PSAInForm Trial. Eur Urol. 2019; pii: S0302-2838(19)30009-0. DOI: 10.1016/j.eururo.2019.01.008.  


  • Stang A, Wellmann I, Kajüter H, Trocchi P, Becker JC, Green AC, Jöckel KH, Khil L. Differences in site-specific incidence and relative survival of cutaneous and mucocutaneous genital squamous cell carcinoma in Germany, 2007-2015. Int J Cancer 2020;147:2772-2779; DOI: 10.1002/ijc.33109


  • Stang A, Khil L, Kajüter H, Pandeya N, Schmults CD, Ruiz ES, Karia PS, Green AC. Incidence and mortality for cutaneous squamous cell carcinoma: comparison across three continents. J Eur Acad Dermatol Venereol. 2019 Dec;33 Suppl 8:6-10. DOI:10.1111/jdv.15967


  • Stang A, Rusner C, Trabert B, Oosterhuis JW, McGlynn KA, Heidinger O. Incidence of testicular tumor subtypes according to the updated WHO classification, North Rhine-Westphalia, Germany, 2008-2013. Andrology. 2019 Jul;7(4):402-407. DOI: 10.1111/andr.12565


  • Thong MSY, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Brenner H, Arndt V.: Age-specific health-related quality of life in long-term and very long-term colorectal cancer survivors versus population controls - a population-based study. Acta Oncol. 2019 Feb 8:1-10. DOI: 10.1080/0284186X.2018.1557340.


  • Trocchi P, Kuss O, Kääb-Sanyal V, Heidinger O, Stang A. Trends in surgical treatment for breast cancer in Germany after the implementation of the mammography screening program. Eur J Epidemiol. 2019 Dec;34(12):1143-1150. doi: 10.1007/s10654-019-00570-x.




  • Bokhof B, Khil L, Urbschat I, Gnas L, Hecht G, Heidinger O, Heindel W, Kieschke J, Weigel S, Hense HW.: Zeitliche Entwicklung der Programmsensitivität des deutschen Mammographie-Screening-Programms in Nordrhein-Westfalen und Niedersachsen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61(12):1517-1527. DOI: 10.1007/s00103-018-2843-7.


  • Braun B., Khil L., Tio J., Krause-Bergmann B., Fuhs A., Heidinger O., Hense H.W.: Differences in breast cancer characteristics by mammography screening participation or non-participation. Dtsch Arztebl Int. 2018;115(31-32):520-527.DOI: 10.3238/arztebl.2018.0520.


  • Kaucher S, Kajüter H, Becher H, Winkler V.: Cancer Incidence and Mortality Among Ethnic German Migrants From the Former Soviet Union. Front Oncol. 2018 Sep 11;8:378. DOI: 10.3389/fonc.2018.00378.


  • Langner I., Krieg V., Heidinger O., Hense H.-W., Zeeb H.: Anreicherung eines GKV-Datensatzes mit amtlichen Todesursachen über einen Abgleich mit dem Epidemiologischen Krebsregister Nordrhein-Westfalen: Machbarkeitsstudie und Methodenvergleich. Gesundheitswesen. 2018. DOI: 10.1055/s-0043-124669.


  • Stang A., Jöckel K.-H., Heidinger O.: Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015). Eur J of Epidemiol. 2018; 33(3): 303-312. DOI: 10.1007/s10654-017-0348-6.


  • Thong MSY, Wolschon E-M, Koch-Gallenkamp L, Waldmann A, Waldeyer-Sauerland M, Pritzkuleit R, Bertram H, Kajüter H, Eberle A, Holleczek B, Zeissig SR, Brenner H, Arndt V.: “Still a Cancer Patient”—Associations of Cancer Identity With Patient-Reported Outcomes and Health Care Use Among Cancer Survivors. JNCI Cancer Spectrum 2018;2(2). DOI: 10.1093/jncics/pky031


  • Weigel S., Gerss J., Hense H.W., Krischke M., Sommer A., Czwoydzinski J., Lenzen H., Kerschke L., Spieker K., Dickmaenken S., Baier S., Urban M., Hecht G., Heidinger O., Kieschke J., Heindel W.: Digital Breast Tomosynthesis plus Synthesised Images versus Standard Fullfield Digital Mammography in Population-based Screening TOSYMA): Protocol of a Randomized Controlled Trial. BMJ Open 2018; 8:e020475. DOI: 10.1136/bmjopen-2017-020475.


  • Weigel S., Khil L., Hense H.W., Decker T., Wellmann J., Heidrich J., Sommer A., Heidinger O., Heindel W.: Detection Rates of Ductal Carcinoma in Situ with Biennial Digital Mammography Screening: Radiologic Findings Support Pathologic Model of Tumor Progression. Radiology. 2018; 286(2): 424-432. DOI: 10.1148/radiol.2017170673.




  • Arndt V, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H.: Quality of life in long-term and very long-term cancer survivors versus population controls in Germany. Acta Oncol. 2017 Feb;56(2):190-197. DOI: 10.1080/0284186X.2016.1266089.


  • Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B,  Schmid-Höpfner S, Waldmann A, Zeissig S, Brenner H, Arndt V.: Progredienzangst ≥5 Jahre nach Krebsdiagnose. Der Onkologe 2017;23(4):295-299. DOI: 10.1007/s00761-017-0188-8.


  • Weigel S, Heindel W, Heidrich J, Hense HW, Heidinger O.: Digital mammography screening: sensitivity of the programme dependent on breast density. Eur Radiol. 2017 Jul;27(7):2744-2751. DOI: 10.1007/s00330-016-4636-4.         



  • Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B,  Schmid-Höpfner S, Waldmann A, Zeissig S, Brenner H, Arndt V.: Fear of recurrence in long-term cancer survivors-Do cancer type, sex, time since diagnosis, and social support matter? Health Psychol. 2016 Dec;35(12):1329-1333. DOI: 10.1037/hea0000374.


  • Schmidtmann I, Sariyar M, Borg A, Gerold-Ay A,Heidinger O, Hense HW, Krieg V, Hammer GP.: Quality of record linkage in a highly automated cancer registry that relies on encrypted identity data. GMS Med Inform Biom Epidemiol 2016;12(1)  DOI: 10.3205/mibe000164. urn:nbn:de:0183-mibe0001640


  • Siegert Y, Jiang X, Krieg V, Bartholomäus S: Classification-Based Record Linkage With Pseudonymized Data for Epidemiological Cancer Registries. IEEE Transactions on Multimedia. 2016; vol. 18, no. 10, pp. 1929-1941. DOI: 10.1109/TMM.2016.2598482.


  • Simbrich A, Wellmann I, Heidrich J, Heidinger O, Hense HW.: Trends in advanced breast cancer incidence rates after implementation of a mammography screening program in a German population. Cancer Epidemiol. 2016 Oct;44:44-51. DOI: 10.1016/j.canep.2016.07.006.


  • Weigel S, Heindel W, Heidrich J, Heidinger O, Hense HW.: Reduction of Advanced Breast Cancer Stages at Subsequent Participation in Mammography Screening. Rofo. 2016 Jan;188(1):33-7. DOI: 10.1055/s-0041-107835.


  • Weigel S, Hense HW, Heidrich J, Berkemeyer S, Heindel W, Heidinger O.: Digital Mammography Screening: Does Age Influence the Detection Rates of Low-, Intermediate-, and High-Grade Ductal Carcinoma in Situ? Radiology. 2016 Mar;278(3):707-13. DOI: 10.1148/radiol.2015150322.




  • Bartholomäus S, Hense HW, Heidinger O.: Blinded Anonymization: a method for evaluating cancer prevention programs under restrictive data protection regulations. Stud Health Technol Inform. 2015;210:424-8. DOI: 10.3233/978-1-61499-512-8-424.


  • Heidinger O, Heidrich J, Batzler WU, Krieg V, Weigel S, Heindel W, Hense HW.: Digital mammography screening in Germany: Impact of age and histological subtype on program sensitivity. Breast. 2015 Jun;24(3):191-6. DOI: 10.1016/j.breast.2014.12.009.


  • Lemke D, Mattauch V, Heidinger O, Pebesma E, Hense HW.: Comparing adaptive and fixed bandwidth-based kernel density estimates in spatial cancer epidemiology. Int J Health Geogr. 2015 Mar 31;14:15. DOI: 10.1186/s12942-015-0005-9.


  • Lemke D, Mattauch V, Heidniger O, Hense HW.: Wer trifft ins Schwarze? Ein qualitativer Vergleich der kostenfreien Geokodierungsdienste von Google und OpenStreetMap. Gesundheitswesen. 2015 Sep;77(8-9):e160-5. DOI 10.1055/s-0035-1549939.


  • Lemke D, Berkemeyer S, Mattauch V, Heidinger O, Pebesma E, Hense HW.: Small-area spatio-temporal analyses of participation rates in the mammography screening program in the city of Dortmund (NW Germany). BMC Public Health. 2015 Nov 28;15:1190. DOI: 10.1186/s12889-015-2520-9.
  • Zeissig SR, Singer S, Koch L, Zeeb H, Merbach M, Bertram H, Eberle A, Schmid-Höpfner S, Holleczek B, Waldmann A, Arndt V.: Utilisation of psychosocial and informational services in immigrant and non-immigrant German cancer survivors. Psychooncology. 2015 Aug;24(8):919-25. DOI: 10.1002/pon.3742.




  • Fuhs A, Bartholomäus S, Heidinger O, Hense HW.: Evaluation der Auswirkungen des Mammographie-Screening-Programms auf die Brustkrebsmortalität - Machbarkeitsstudie zur Verknüpfung verschiedener Datenquellen in Nordrhein-Westfalen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Jan;57(1):60-7. DOI: 10.1007/s00103-013-1870-7.


  • Geier AS, Wellmann I, Wellmann J, Kajüter H, Heidinger O, Hempel G, Hense HW.: Patterns and determinants of new first-line antihyperglycaemic drug use in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2014 Oct;106(1):73-80. DOI: 10.1016/j.diabres.2014.07.014.


  • Jansen L, Eberle A, Emrich K, Gondos A, Holleczek B, Kajüter H, Maier W, Nennecke A, Pritzkuleit R, Brenner H; GEKID Cancer Survival Working Group.: Socioeconomic deprivation and cancer survival in Germany: an ecological analysis in 200 districts in Germany. Int J Cancer. 2014 Jun 15;134(12):2951-60. DOI: 10.1002/ijc.28624.


  • Kajüter H, Geier AS, Wellmann I, Krieg V, Fricke R, Heidinger O, Hense HW.: Kohortenstudie zur Krebsinzidenz bei Patienten mit Diabetes mellitus Typ 2 - Record Linkage von kryptografierten Daten einer externen Kohorte mit Daten des Epidemiologischen Krebsregisters Nordrhein-Westfalen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Jan;57(1):52-9. DOI: 10.1007/s00103-013-1880-5


  • Koch L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V.: Fear of recurrence in long-term breast cancer survivors-still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the cancer survivorship--a multi-regional population-based study. Psychooncology. 2014 May;23(5):547-54. DOI: 10.1002/pon.3452.


  • Radespiel-Tröger M, Batzler WU, Holleczek B, Luttmann S, Pritzkuleit R, Stabenow R, Urbschat I, Zeissig SR, Meyer M; Im Namen der Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V.: Inzidenzzunahme des papillären Schilddrüsenkarzinoms in Deutschland. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Jan;57(1):84-92. DOI: 10.1007/s00103-013-1884-1.


  • Urbschat I, Heidinger O.:    Ermittlung der Rate von Intervallkarzinomen im deutschen Mammographie-Screening-Programm mit Hilfe epidemiologischer Krebsregister. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Jan;57(1):68-76. DOI: 10.1007/s00103-013-1883-2.


  • Weigel S, Heindel W, Heidinger O, Berkemeyer S, Hense HW.: Digital mammography screening: association between detection rate and nuclear grade of ductal carcinoma in situ. Radiology. 2014 Apr;271(1):38-44. DOI: 10.1148/radiol.13131498.




  • Geier AS, Wellmann J, Wellmann I, Kajüter H, Heidinger O, Hempel G, Hense HW.: Cancer detection rates following enrolment in a disease management programme for type 2 diabetes. Diabetologia. 2013 Sep;56(9):1944-8. DOI: 10.1007/s00125-013-2947-4.


  • Heidinger O, Bartholomäus S, Mattauch V.: Elektronische Meldewege im Kontext klinischer und epidemiologischer Krebsregistrierung - Vorteile und Probleme. Der Onkologe 2013;12. https://doi.org/10.1007/s00761-013-2518-9.


  • Koch L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V.: Lebensqualität von Langzeitüberlebenden nach Brust-, Darm- und Prostatakrebs. Forum 2013; 28(1):43–47. https://doi.org/10.1007/s12312-012-0907-4.


  • Lemke D, Mattauch V, Heidinger O, Pebesma E, Hense HW.: Detecting cancer clusters in a regional population with local cluster tests and Bayesian smoothing methods: a simulation study. Int J Health Geogr. 2013 Dec 7;12:54. DOI: 10.1186/1476-072X-12-54.


  • Nennecke A, Barnes B, Brenner H, Eberle A, Emrich K, Eisemann N, Geiss K, Hentschel S, Holleczek B, Kraywinkel K, Stabenow R, Hense HW.: Datenqualität oder Unterschiede in der onkologischen Versorgung? – Berichtsstandards für Überlebenszeitanalysen mit Krebsregisterdaten. Gesundheitswesen. 2013 Feb;75(2):94-8. DOI: 10.1055/s-0032-1311622.


  • Sariyar M, Borg A, Heidinger O, Pommerening K.: A practical framework for data management processes and their evaluation in population-based medical registries. Inform Health Soc Care. 2013 Mar;38(2):104-19. DOI: 10.3109/17538157.2012.735731.




  • Breckenkamp J, Spallek J, Kraywinkel K, Krieg V, Schwabe W, Greiner W, Damm O, Hense H, Razum O.: Abgleich von Verwaltungsdaten des Medizinischen Dienstes der Krankenversicherung mit Krebsregisterdaten. Gesundheitswesen. 2012 Jul;74(7):e52-60. DOI: 10.1055/s-0031-1286274.


  • Heidinger O, Batzler WU, Krieg V, Weigel S, Biesheuvel C, Heindel W, Hense HW.: The incidence of interval cancers in the German mammography screening program: results from the population-based cancer registry in North Rhine-Westphalia. Dtsch Arztebl Int. 2012 Nov;109(46):781-7. DOI: 10.3238/arztebl.2012.0781.


  • Kajüter H, Batzler WU, Krieg V, Heidinger O, Hense HW.: Abgleich von Sekundärdaten mit einem epidemiologischen Krebsregister auf der Basis verschlüsselter Personendaten – Ergebnisse einer Pilotstudie in Nordrhein-Westfalen. Gesundheitswesen. 2012 Aug;74(8-9):e84-9. DOI: 10.1055/s-0032-1314828.




  • Hense HW, Kajüter H, Wellmann J, Batzler WU.: Cancer incidence in type 2 diabetes patients - first results from a feasibility study of the D2C cohort. Diabetol Metab Syndr. 2011 Jul 13;3(1):15. DOI: 10.1186/1758-5996-3-15.



  • Nennecke A, Brenner H, Eberle A, Geiss K, Holleczek B, Kieschke J, Kraywinkel K.: Überlebenschancen von Krebspatienten in Deutschland – auf dem Weg zu repräsentativen, vergleichbaren Aussagen. Gesundheitswesen. 2010 Oct;72(10):692-9. DOI: 10.1055/s-0029-1242772.



  • Krieg V, Hense HW, Lehnert M, Mattauch V.: Record Linkage mit kryptografierten Identitätsdaten in einem bevölkerungsbezogenen Krebsregister. Gesundheitswesen. 2001 Jun;63(6):376-82. DOI: 10.1055/s-2001-15686.